| Lung Cancer |
1 |
1 |
| Cancer |
0 |
0.66 |
| Lung |
0 |
0.66 |
| Biologic Therapy |
0 |
0.57 |
| Social Determinants of Health |
0 |
0.23 |
| Health Care Quality, Access, and Evaluation |
0 |
0.18 |
| CT Scan |
0 |
0.16 |
| Adverse Effects |
0 |
0.09 |
| Arkansas |
0 |
0.09 |
| Mississippi |
0 |
0.09 |
| Patient Safety |
0 |
0.09 |
| Preventive Screening |
0 |
0.09 |
| Surgery |
0 |
0.09 |
| Tennessee |
0 |
0.09 |
| Tobacco Cessation |
0 |
0.08 |
| West Virginia |
0 |
0.06 |
| Antiretroviral Therapy for HIV Infection |
0 |
0.05 |
| Electronic Health Record (EHR) and Healthcare Technology |
0 |
0.05 |
| HIV Infection |
0 |
0.05 |
| Alabama |
0 |
0.04 |
| Clinical Research |
0 |
0.04 |
| Immunotherapy |
0 |
0.04 |
| Kentucky |
0 |
0.04 |
| Medical Innovations |
0 |
0.04 |
| Nucleoside Reverse Transcriptase Inhibitors |
0 |
0.04 |
| Poverty |
0 |
0.04 |
| Scan |
0 |
0.04 |
| Tobacco Use |
0 |
0.04 |
| Tumor |
0 |
0.04 |
| Uninsured |
0 |
0.04 |
| Virginia |
0 |
0.04 |